About the project

 

V.A. Cure is a European MSCA-ITN network aiming to uncover core mechanisms of initiation and maintenance of Vascular Anomalies (VAs) and to leverage this information for establishing novel therapeutic strategies. The network consortium consists of 7 academic laboratories and 2 companies from across Europe, and is supported by 9 partner organisations.
The 14 Early Stage Researchers (ESRs) will be a part of  the unique international PhD program, consisting of an individual research project, the network’s training programme, intersectoral secondments and outreach activities. Project goal is to  ensure a comprehensive perception of the research and drug/technology development in pharma industry/biotech and academia.

News

  • Rare Disease Day

    Project made origami’s for origami carpet and will attend Edelweiss awards in Brussels! Origami carpet can be seen at the gallery Saint Hubert on Rare Disease Day! 29th of February is approaching!

  • Fist Network meeting

    14 students, 10 supervisors and 4 partner organisations participated on the 3 day extensive networking, training and workshops of the V.A.Cure project held from 13-15th of November in de Duve Institute in Brussels.

  • Embracing diversity

    Diversity and environment that fosters equal opportunities in research are very important aspects of our project. Through inclusion of diversity, we grow professionally and personally.Early stage researchers of V.A.Cure project are coming from all over the world: Singapore, Iran, Vietnam, Turkey, Italy, Germany, Slovenia, Lebanon, Austria, Spain and USA.

  • Gender balance in our research

    Equal participation of men and women in science is a topic of a high global importance. Thus, equal opportunities during selection process were important aspect of our project. Therefore, we are proud to announce that we have obtained gender equality in our team of 14 Early Stage Researchers.

V.A. Cure
@VACure1



As #VAcure family, we are still working from home to keep the research ongoing for people with rare diseases. Be safe! #stayathome #EvdeKal #BleibtZuhause #blijfthuis #restezalamaison #stannahemma #staiacasa

View on Twitter

1

2

Follow us on Facebook

Project has received funding from the European Union’s Horizon 2020 research and innovation programme under the Marie Skłodowska-Curie grant agreement No 814316